Laboratory Medicine and Quality Assurance

Table. 2.

Acceptable rates based on urine analyzers of different companies

Instrument No. (%) pH Protein Glucose Ketone Bilirubin Blood Urobilinogen Nitrite Leukocyte
1st proficiency test
YD 660 (41.6) 95.2 99.4 96.8 99.5 99.1 99.1 99.5 99.6 99.2
Abbott 415 (26.1) 99.0 96.1 96.8 99.6 99.5 99.3 98.3 99.6 99.5
Roche 175 (11.0) 95.7 99.4 98.9 99.9 99.6 99.3 90.6 99.9 99.9
DFI 149 (9.4) 96.8 88.4 97.1 99.7 99.5 98.7 99.2 98.0 99.1
Sysmex 121 (7.6) 99.8 100.0 100.0 100.0 99.6 99.6 98.6 100.0 100.0
Siemens 103 (6.5) 88.1 100.0 99.8 99.8 70.9 100.0 90.0 99.5 99.5
Eiken 17 (1.1) 92.7 100.0 100.0 99.9 95.0 98.5 100.0 96.7 100.0
Arkray 15 (0.9) 98.3 100.0 100.0 100.0 76.7 88.3 76.7 100.0 100.0
URIT 11 (0.7) 93.2 100.0 100.0 100.0 100.0 100.0 79.6 100.0 97.7
2nd proficiency test
YD 661 (41.4) 95.0 99.8 97.4 99.7 99.2 99.0 99.5 99.8 97.0
Abbott 428 (26.8) 97.9 98.9 97.7 99.7 99.3 98.7 99.0 99.7 99.5
Roche 174 (10.9) 94.4 99.7 99.3 100.0 99.7 99.0 90.9 99.0 99.3
DFI 145 (9.1) 97.6 94.8 99.1 99.3 99.0 97.2 98.4 98.4 96.5
Sysmex 123 (7.7) 100.0 100.0 100.0 100.0 99.8 99.8 98.2 75.0 99.8
Siemens 102 (6.4) 88.1 100.0 99.8 100.0 72.8 99.8 90.5 100.0 99.3
Eiken 17 (1.1) 92.7 100.0 98.5 100.0 90.0 98.5 100.0 100.0 100.0
Arkray 15 (0.9) 100.0 100.0 100.0 100.0 75.0 100.0 75.0 100.0 100.0
URIT 11 (0.7) 97.7 100.0 97.7 100.0 100.0 100.0 79.6 100.0 100.0
3rd proficiency test
YD 681 (42.4) 93.6 99.7 96.9 99.8 99.7 99.7 96.9 99.6 98.5
Abbott 425 (26.4) 99.4 98.8 98.6 99.2 99.9 99.6 98.1 99.5 88.8
Roche 175 (10.9) 99.6 100.0 99.7 100.0 100.0 100.0 94.7 96.8 99.9
DFI 140 (8.7) 97.5 97.2 98.8 99.8 100.0 99.5 94.9 99.7 97.2
Sysmex 131 (8.2) 99.8 100.0 100.0 56.3 100.0 100.0 61.1 99.8 52.3
Siemens 106 (6.6) 98.4 100.0 98.1 98.8 100.0 99.8 79.3 100.0 99.1
Eiken 15 (0.9) 93.3 100.0 100.0 100.0 96.2 100.0 100.0 100.0 100.0
URIT 12 (0.7) 100.0 100.0 100.0 100.0 100.0 100.0 97.9 97.9 97.9
Arkray 11 (0.7) 100.0 100.0 100.0 100.0 100.0 100.0 50.0 100.0 100.0

Values are presented as number (%) or percentage. Results with <90% accuracy are indicated in bold type. The instruments used were as follows: YD (YD Diagnostics, Yongin, Korea), Abbott (Abbott Laboratories, Abbott Park, IL, USA), Roche (Roche Diagnostics, Mannheim, Germany), DFI (DFI Co. Ltd., Gimhae, Korea), Sysmex (Sysmex Co., Kobe, Japan), Siemens (Siemens Healthcare, Erlangen, Germany), Eiken (Eiken Chemical Co., Tokyo, Japan), URIT (URIT Medical Electronic, Guangxi, China), and Arkray (Arkray Inc., Kyoto, Japan).

Lab Med Qual Assur 2023;45:125~134 https://doi.org/10.15263/jlmqa.2023.45.4.125
© Lab Med Qual Assur